Standard Chemical & Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 4.36%

Standard Chemical & Pharmaceutical Co Ltd (1720) has an Asset Resilience Ratio of 4.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Standard Chemical & Pharmaceutical Co Lt (1720) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

NT$506.44 Million

≈ $15.96 Million USD Cash + Short-term Investments

Total Assets

NT$11.62 Billion

≈ $366.20 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Standard Chemical & Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 1720 net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Standard Chemical & Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 1720 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$506.44 Million	4.36%
Total Liquid Assets	NT$506.44 Million	4.36%

Asset Resilience Insights

Limited Liquidity: Standard Chemical & Pharmaceutical Co Ltd maintains only 4.36% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Standard Chemical & Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Standard Chemical & Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Standard Chemical & Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.61%	NT$291.86 Million ≈ $9.20 Million	NT$11.18 Billion ≈ $352.09 Million	+0.48pp
2023-12-31	2.13%	NT$238.79 Million ≈ $7.52 Million	NT$11.19 Billion ≈ $352.51 Million	-0.96pp
2022-12-31	3.10%	NT$339.66 Million ≈ $10.70 Million	NT$10.97 Billion ≈ $345.56 Million	-1.11pp
2021-12-31	4.20%	NT$424.84 Million ≈ $13.38 Million	NT$10.10 Billion ≈ $318.33 Million	-2.11pp
2020-12-31	6.31%	NT$445.10 Million ≈ $14.02 Million	NT$7.05 Billion ≈ $222.10 Million	+3.13pp
2019-12-31	3.18%	NT$220.27 Million ≈ $6.94 Million	NT$6.93 Billion ≈ $218.27 Million	+0.13pp
2018-12-31	3.05%	NT$196.48 Million ≈ $6.19 Million	NT$6.44 Billion ≈ $202.87 Million	-0.28pp
2017-12-31	3.34%	NT$212.65 Million ≈ $6.70 Million	NT$6.37 Billion ≈ $200.82 Million	-1.27pp
2016-12-31	4.61%	NT$286.93 Million ≈ $9.04 Million	NT$6.23 Billion ≈ $196.15 Million	+1.67pp
2015-12-31	2.94%	NT$170.12 Million ≈ $5.36 Million	NT$5.80 Billion ≈ $182.58 Million	-0.41pp
2014-12-31	3.34%	NT$179.59 Million ≈ $5.66 Million	NT$5.37 Billion ≈ $169.33 Million	-1.21pp
2013-12-31	4.55%	NT$243.39 Million ≈ $7.67 Million	NT$5.35 Billion ≈ $168.65 Million	+0.18pp
2012-12-31	4.37%	NT$223.90 Million ≈ $7.05 Million	NT$5.12 Billion ≈ $161.41 Million	-0.85pp
2011-12-31	5.22%	NT$254.03 Million ≈ $8.00 Million	NT$4.87 Billion ≈ $153.31 Million	-1.40pp
2010-12-31	6.62%	NT$299.40 Million ≈ $9.43 Million	NT$4.52 Billion ≈ $142.39 Million	+1.13pp
2009-12-31	5.49%	NT$211.08 Million ≈ $6.65 Million	NT$3.84 Billion ≈ $121.11 Million	-5.51pp
2008-12-31	11.00%	NT$390.42 Million ≈ $12.30 Million	NT$3.55 Billion ≈ $111.79 Million	-10.98pp
2007-12-31	21.98%	NT$726.55 Million ≈ $22.89 Million	NT$3.31 Billion ≈ $104.13 Million	-1.34pp
2006-12-31	23.33%	NT$813.66 Million ≈ $25.63 Million	NT$3.49 Billion ≈ $109.89 Million	-3.88pp
2005-12-31	27.21%	NT$933.56 Million ≈ $29.41 Million	NT$3.43 Billion ≈ $108.11 Million	-0.56pp
2004-12-31	27.77%	NT$943.35 Million ≈ $29.72 Million	NT$3.40 Billion ≈ $107.03 Million	+6.79pp
2003-12-31	20.98%	NT$688.35 Million ≈ $21.69 Million	NT$3.28 Billion ≈ $103.37 Million	+6.22pp
2002-12-31	14.76%	NT$420.76 Million ≈ $13.26 Million	NT$2.85 Billion ≈ $89.84 Million	--

pp = percentage points

About Standard Chemical & Pharmaceutical Co Ltd

TW:1720 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$352.43 Million

NT$11.19 Billion TWD

Market Cap Rank

#14198 Global

#600 in Taiwan

Share Price

NT$62.60

Change (1 day)

-0.32%

52-Week Range

NT$54.10 - NT$65.60

All Time High

NT$77.40